GlassScriptPhysician profile
Aaron D Lee
NPI 1831455575
$2,383.14
in general payments reported to CMS, 2019-2025
16 companies · $915 in 2025
The $915 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $237 · 2022: $23.71 · 2023: $254 · 2024: $953 · 2025: $915.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,122.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $237.60 | 2025 | Rezdiffra |
| Intuitive Surgical, INC. | $236.95 | 2020 | |
| Janssen Biotech, INC. | $235.87 | 2024-2025 | Tremfya, Stelara |
| Gilead Sciences, INC. | $221.61 | 2025 | |
| Janssen Scientific Affairs, LLC | $195.88 | 2023-2024 | |
| Terumo Medical Corporation | $178.68 | 2024 | Azur Cx Detachable |
| Abbott Laboratories | $169.60 | 2025 | Amplatzer Amulet |
| Olympus America INC. | $160.12 | 2025 | Olympus, Visiglide, Single Use Repositionable Clip |
| Mallinckrodt Hospital Products INC. | $149.79 | 2024 | Terlivaz |
| Abbvie INC. | $123.74 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $123.74 | 2024 | Zeposia |
| Astrazeneca Pharmaceuticals LP | $117.42 | 2024 | Imfinzi |
| Cook Medical LLC | $113.67 | 2024 | Hemospray |
| Ipsen Biopharmaceuticals, INC | $73.33 | 2024 | Iqirvo |
| Integra Lifesciences Corporation | $23.71 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $21.43 | 2023 | Emblem Mri S-Icd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.